Journal: Brazilian Journal of Microbiology

Article Title: Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters

doi: 10.1007/s42770-020-00242-z

Figure Lengend Snippet: Effects of antifungal agents on planktonic and sessile cells and biofilms of Candida spp

Article Snippet: FLZ again presented lower performance and, again, greater variability in relation to the others (81.82–100%) (Table ). table ft1 table-wrap mode="anchored" t5 Table 3 caption a7 Test Strains Biofilm Activity (%) AND FLZ VRZ KTZ AMB Inhibition of biofilm formation CA CV42 100 97.97 100 100 100 CA CV44 100 50.00 78.16 89.47 98.68 CA DEB23 100 93.73 97.98 97.46 99.96 ATCC 750 100 100 100 93.24 100 CT 72A 100 69.84 79.69 99.62 97.91 CT RL104 100 99.31 98.51 99.56 100 ATCC 22019 100 96.83 99.98 99.98 90.36 CP RL27m 100 99.74 100 99.67 79.19 CP RL100 100 92.95 97.65 79.73 98.72 Average 100 88.93 94.66 95.41 96.09 Coefficient of variation 0 19.52 9.49 7.27 7.32 Biofilm eradication CA CV42 100 89.54 100 98.95 99,99 CA CV44 100 81.82 99.93 99.89 100 CA DEB23 100 98.40 100 95.88 100 ATCC 750 100 99.79 100 99.79 100 CT 72A 100 99.82 99.45 99.90 100 CT RL104 100 99.04 99.65 99.76 99.36 ATCC 22019 100 100 100 99.94 100 CP RL27m 99.64 82.17 97.24 99.37 98.95 CP RL100 100 90.56 99.94 99.92 81.13 Average 99.96 93.46 99.58 99.26 97.70 Coefficient of variation 0.12 8.16 0.90 1.32 6.38 Open in a separate window Biofilm activity (%): percentage of inhibition compared to the control.

Techniques: Concentration Assay, Inhibition

Journal: Brazilian Journal of Microbiology

Article Title: Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters

doi: 10.1007/s42770-020-00242-z

Figure Lengend Snippet: Effects of antifungal agents on Candida biofilms in central venous polyurethane catheter surface

Article Snippet: FLZ again presented lower performance and, again, greater variability in relation to the others (81.82–100%) (Table ). table ft1 table-wrap mode="anchored" t5 Table 3 caption a7 Test Strains Biofilm Activity (%) AND FLZ VRZ KTZ AMB Inhibition of biofilm formation CA CV42 100 97.97 100 100 100 CA CV44 100 50.00 78.16 89.47 98.68 CA DEB23 100 93.73 97.98 97.46 99.96 ATCC 750 100 100 100 93.24 100 CT 72A 100 69.84 79.69 99.62 97.91 CT RL104 100 99.31 98.51 99.56 100 ATCC 22019 100 96.83 99.98 99.98 90.36 CP RL27m 100 99.74 100 99.67 79.19 CP RL100 100 92.95 97.65 79.73 98.72 Average 100 88.93 94.66 95.41 96.09 Coefficient of variation 0 19.52 9.49 7.27 7.32 Biofilm eradication CA CV42 100 89.54 100 98.95 99,99 CA CV44 100 81.82 99.93 99.89 100 CA DEB23 100 98.40 100 95.88 100 ATCC 750 100 99.79 100 99.79 100 CT 72A 100 99.82 99.45 99.90 100 CT RL104 100 99.04 99.65 99.76 99.36 ATCC 22019 100 100 100 99.94 100 CP RL27m 99.64 82.17 97.24 99.37 98.95 CP RL100 100 90.56 99.94 99.92 81.13 Average 99.96 93.46 99.58 99.26 97.70 Coefficient of variation 0.12 8.16 0.90 1.32 6.38 Open in a separate window Biofilm activity (%): percentage of inhibition compared to the control.

Techniques: Activity Assay, Inhibition

Journal: Brazilian Journal of Microbiology

Article Title: Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters

doi: 10.1007/s42770-020-00242-z

Figure Lengend Snippet: Effects of antifungal agents alone and in combination, in solution, and in a formulation of a film-forming system on Candida spp. biofilms in central venous polyurethane catheter surface

Article Snippet: FLZ again presented lower performance and, again, greater variability in relation to the others (81.82–100%) (Table ). table ft1 table-wrap mode="anchored" t5 Table 3 caption a7 Test Strains Biofilm Activity (%) AND FLZ VRZ KTZ AMB Inhibition of biofilm formation CA CV42 100 97.97 100 100 100 CA CV44 100 50.00 78.16 89.47 98.68 CA DEB23 100 93.73 97.98 97.46 99.96 ATCC 750 100 100 100 93.24 100 CT 72A 100 69.84 79.69 99.62 97.91 CT RL104 100 99.31 98.51 99.56 100 ATCC 22019 100 96.83 99.98 99.98 90.36 CP RL27m 100 99.74 100 99.67 79.19 CP RL100 100 92.95 97.65 79.73 98.72 Average 100 88.93 94.66 95.41 96.09 Coefficient of variation 0 19.52 9.49 7.27 7.32 Biofilm eradication CA CV42 100 89.54 100 98.95 99,99 CA CV44 100 81.82 99.93 99.89 100 CA DEB23 100 98.40 100 95.88 100 ATCC 750 100 99.79 100 99.79 100 CT 72A 100 99.82 99.45 99.90 100 CT RL104 100 99.04 99.65 99.76 99.36 ATCC 22019 100 100 100 99.94 100 CP RL27m 99.64 82.17 97.24 99.37 98.95 CP RL100 100 90.56 99.94 99.92 81.13 Average 99.96 93.46 99.58 99.26 97.70 Coefficient of variation 0.12 8.16 0.90 1.32 6.38 Open in a separate window Biofilm activity (%): percentage of inhibition compared to the control.

Techniques: Activity Assay, Inhibition